Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Zhou, Yanming ^a,b   Zhao, Yanfang ^b   Li, Bin ^a   Xu, Donghui ^a   Yin, Zhengfeng ^b   Xie, Feng ^b   Yang, Jiamei ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER RESECTION; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; RADIOFREQUENCY ABLATION; SAFETY; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TUMOR VOLUME; ADULT; AGED; CATHETER ABLATION; FEMALE; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77954334672     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-78     Document Type: Article

References (33)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
2. Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005, 128:1752-1764. 10.1053/j.gastro.2005.03.033, 15887162.
3. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998, 14:171-174. 10.1002/(SICI)1098-2388(199803)14:2<171::AID-SSU9>3.0.CO;2-2, 9492887.
4. Danila M, Sporea I, Sirli R, Popescu A. Percutaneous ethanol injection therapy in the treatment of hepatocarcinoma--results obtained from a series of 88 cases. J Gastrointestin Liver Dis 2009, 18:317-322.
5. Huo TI, Huang YH, Huang HC, Wu JC, Lee PC, Chang FY, Lee SD. Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis. J Clin Gastroenterol 2006, 40:639-642. 10.1097/00004836-200608000-00017, 16917410.
6. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009, 249:20-25. 10.1097/SLA.0b013e31818eec29, 19106671.
7. Kawamoto C, Ido K, Isoda N, Hozumi M, Nagamine N, Ono K, Sato Y, Kobayashi Y, Nagae G, Sugano K. Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. Cancer 2005, 103:985-993. 10.1002/cncr.20880, 15672389.
8. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990, 11:181-184. 10.1016/0168-8278(90)90110-D, 2174933.
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. 10.1002/hep.20933, 16250051.
10. Bouza C, López-Cuadrado T, Alcázar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009, 9:31. 10.1186/1471-230X-9-31, 19432967.
11. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33:1394-1403. 10.1053/jhep.2001.24563, 11391528.
12. Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, Matsuda Y, Watanabe M, Aoyagi Y, Hatakeyama K. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or = 4 cm. World J Gastroenterol 2006, 12:546-552.
13. Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM, Li SQ. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006, 86:801-805.
14. Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008, 195:829-836. 10.1016/j.amjsurg.2007.10.010, 18436176.
15. Ogihara M, Wong LL, Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: Long-term outcomes. HPB (Oxford) 2005, 7:214-221. 2023955, 18333193.
16. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, . Kagoshima Liver Cancer Study Group Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009, 16:359-366. 10.1007/s00534-009-0069-7, 19300896, Kagoshima Liver Cancer Study Group.
17. Kudo M, Chung H. Single HCC between 2 and 5 cm: the grey zone: Hepatologist's perspective. J Hepatobiliary Pancreat Surg 2009,
18. Ikeda K, Kobayashi M, Saitoh S, Someya T, Hosaka T, Sezaki H, Suzuki Y, Suzuki F, Akuta N, Arase Y, Kumada H, Matsuda M, Hashimoto M, Watanabe G. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3 cm or less in diameter. Hepatol Res 2005, 33:241-249. 10.1016/j.hepres.2005.09.002, 16260178.
19. Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008, 49:589-594. 10.1016/j.jhep.2008.05.018, 18620773.
20. Hasegawa K, Kokudo N, Sano K, Makuuchi M. Single HCC between 2 and 5 cm: the grey zone: Surgeon's perspective. J Hepatobiliary Pancreat Surg 2009,
21. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004, 240:102-107. 10.1097/01.sla.0000129672.51886.44, 1356381, 15213625.
22. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005, 39:247-252. 10.1097/01.mcg.0000152746.72149.31, 15718869.
23. Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI. The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma. Korean J Hepatol 2005, 11:59-71.
24. Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008, 12:1521-1526. 10.1007/s11605-008-0553-4, 18592325.
25. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006, 243:321-328. 10.1097/01.sla.0000201480.65519.b8, 1448947, 16495695.
26. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?. HPB (Oxford) 2007, 9:429-434. 2215355, 18345289.
27. Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, Martone E, Nicoli P, Iacono C. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008, 12:192-8. 10.1007/s11605-007-0392-8, 17999123.
28. Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, Ninomiya T, Otomi Y, Kokame M, Iwamura T, Ishimaru Y, Sogabe I, Kashihara K, Nishiura S, Ootani H, Takamura K, Kawasaki H. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 2008, 55:2171-2174.
29. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A, Costa M. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005, 9:62-67. 10.1016/j.gassur.2004.10.003, 15623446.
30. Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, Costa M, Conti M, Montorsi M. Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver Cirrhosis. Ann Surg Oncol 2009, 16:3289-3298. 10.1245/s10434-009-0678-z, 19727960.
31. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003, 17:1247-1261. 10.1046/j.1365-2036.2003.01580.x, 12755838.
32. Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S, Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol 2008, 43:71-78. 10.1007/s00535-007-2123-z, 18297439.
33. Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996, 77:2022-2031. 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S, 8640665.